Natural products as leads for tuberculosis drug development

Current Topics in Medicinal Chemistry

Volumn 12, Issue 7, 2012, Pages 735-765

  Salomon, Christine E ^a   Schmidt, Lori E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Drug development; Drug resistant tuberculosis; Mycobacterium tuberculosis; Natural products; Structure activity relationship; Tuberculosis

Indexed keywords

ALLIUM NEAPOLITANUM EXTRACT; AMAMISTATIN A; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; BENZOPYRAN DERIVATIVE; CANTHIN 6 ONE DERIVATIVE; CHLOROFORM; CYCLODEPSIPEPTIDE; DERRIS INDICA EXTRACT; ENGELHARDIA ROXBURGHIANA EXTRACT; ERYTHROPHLOIN; EVOCARPINE; FLAVONOID; FUROCOUMARIN; GAMMA LACTONE DERIVATIVE; GARCINIA LINII EXTRACT; HERBACEOUS AGENT; LYDIAMYCIN A; MOLLICELLIN K; PHENOL DERIVATIVE; PLANT EXTRACT; PSEUDOPYRONINES A; QUINOLONE DERIVATIVE; QUINONE DERIVATIVE; SANSANMYCIN A; SCROPHULARIA DESERTI EXTRACT; TOVOMITA LONGIFOLIA EXTRACT; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACTINOBACTERIA; ANTIFUNGAL ACTIVITY; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ASTHMA; BREAST CANCER; CANCER CELL CULTURE; COUGHING; IN VITRO STUDY; IN VIVO STUDY; IPOMOEA NIL; LUNG CANCER; MEDICINAL PLANT; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM PHLEI; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PIPER SARMENTOSUM; PLANT PRODUCT; PLEURISY; PSEUDOMONAS; REVIEW; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; TOOTH PAIN; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; BIOLOGICAL AGENTS; DRUG DISCOVERY; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84860279237     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612799984526     Document Type: Review

References (182)

1. Donoghue, H.D. Human tuberculosis - an ancient disease, as elucidated by ancient microbial biomolecules. Microbes Infect., 2009, 11, 1156-1162.
2. Hershkovitz, I.; Donoghue, H.D.; Minnikin, D.E.; Besra, G.S.; Lee, O.Y.C.; Gernaey, A.M.; Galili, E.; Eshed, V.; Greenblatt, C.L.; Lemma, E.; Bar-Gal, G.K.; Spigelman, M. Detection and molecular characterization of 9000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the eastern Mediterranean. Plos One, 2008, 3, e3426.
3. Smith, N.H.; Hewinson, R.G.; Kremer, K.; Brosch, R.; Gordon, S.V. Myths and misconceptions: The origin and evolution of Mycobacterium tuberculosis. Nat. Rev. Microbiol., 2009, 7, 537-544.
4. Janick, J. Herbals: The connection between horticulture and medicine. HortTechnology, 2003, 13, 229-238.
5. Cragg, G.M.; Newman, D.J. Biodiversity: A continuing source of novel drug leads. Pure Appl. Chem., 2005, 77, 7-24.
6. Gautam, R.; Saklani, A.; Jachak, S.M. Indian medicinal plants as a source of antimycobacterial agents. J. Ethnopharmacol., 2007, 110, 200-234.
7. McGaw, L.J.; Lall, N.; Meyer, J.J.M.; Eloff, J.N. The potential of South African plants against Mycobacterium infections. J. Ethnopharmacol., 2008, 119, 482-500.
8. Tabuti, J.R.S.; Kukunda, C.B.; Waako, P.J. Medicinal plants used by traditional medicine practitioners in the treatment of tuberculosis and related ailments in Uganda. J. Ethnopharmacol., 2010, 127, 130-136.
9. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod., 2007, 70, 461-477.
10. Dobson, C.M. Chemical space and biology. Nature, 2004, 432, 824-828.
11. Koch, M.A.; Schuffenhauer, A.; Scheck, M.; Wetzel, S.; Casaulta, M.; Odermatt, A.; Ertl, P.; Waldmann, H. Charting biologically relevant chemical space: A structural classification of natural products (SCONP). Proc. Natl. Acad. Sci. USA, 2005, 102, 17272-17277.
12. Maggi, N.; Pasqualucci, C.R.; Ballotta, R.; Sensi, P. Rifampicin: a new orally active rifamycin. Chemotherapy, 1966, 11, 285-292.
13. Cole, S.T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C.; Harris, D.; Gordon, S.V.; Eiglmeier, K.; Gas, S.; Barry, C.E.; Tekaia, F.; Badcock, K.; Basham, D.; Brown, D.; Chillingworth, T.; Connor, R.; Davies, R.; Devlin, K.; Feltwell, T.; Gentles, S.; Hamlin, N.; Holroyd, S.; Hornsby, T.; Jagels, K.; Krogh, A.; McLean, J.; Moule, S.; Murphy, L.; Oliver, K.; Osborne, J.; Quail, M.A.; Rajandream, M.A.; Rogers, J.; Rutter, S.; Seeger, K.; Skelton, J.; Squares, R.; Squares, S.; Sulston, J.E.; Taylor, K.; Whitehead, S.; Barrell, B.G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998, 393, 537-544.
14. Sassetti, C.M.; Boyd, D.H.; Rubin, E.J. Comprehensive identification of conditionally essential genes in mycobacteria. Proc. Natl. Acad. Sci. USA, 2001, 98, 12712-12717.
15. Sassetti, C.M.; Rubin, E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA, 2003, 100, 12989-12994.
16. Andries, K.; Verhasselt, P.; Guillemont, J.; Gohlmann, H.W.H.; Neefs, J.M.; Winkler, H.; Van Gestel, J.; Timmerman, P.; Zhu, M.; Lee, E.; Williams, P.; de Chaffoy, D.; Huitric, E.; Hoffner, S.; Cambau, E.; Truffot-Pernot, C.; Lounis, N.; Jarlier, V. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science, 2005, 307, 223-227.
17. Stover, C.K.; Warrener, P.; VanDevanter, D.R.; Sherman, D.R.; Arain, T.M.; Langhorne, M.H.; Anderson, S.W.; Towell, J.A.; Yuan, Y.; McMurray, D.N.; Kreiswirth, B.N.; Barry, C.E.; Baker, W.R. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature, 2000, 405, 962-966.
18. Matsumoto, M.; Hashizume, H.; Tomishige, T.; Kawasaki, M.; Tsubouchi, H.; Sasaki, H.; Shimokawa, Y.; Komatsu, M. OPC- 67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS Med, 2006, 3, e466.
19. Lee, R.E.; Protopopova, M.; Crooks, E.; Slayden, R.A.; Terrot, M.; Barry, C.E. Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates. J. Comb. Chem., 2003, 5, 172-187.
20. http://www.tballiance.org/home/home.php.
21. Diacon, A.H.; Pym, A.; Grobusch, M.; Patientia, R.; Rustomjee, R.; Page-Shipp, L.; Pistorius, C.; Krause, R.; Bogoshi, M.; Churchyard, G.; Venter, A.; Allen, J.; Palomino, J.C.; De Marez, T.; van Heeswijk, R.P.G.; Lounis, N.; Meyvisch, P.; Verbeeck, J.; Parys, W.; de Beule, K.; Andries, K.; Mc Neeley, D.F. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. New Eng. J. Med., 2009, 360, 2397-2405.
22. Koul, A.; Vranckx, L.; Dendouga, N.; Balemans, W.; Van den Wyngaert, I.; Vergauwen, K.; Goehlmann, H.W.H.; Willebrords, R.; Poncelet, A.; Guillemont, J.; Bald, D.; Andries, K. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J. Biol. Chem., 2008, 283, 25273-25280.
23. Barker, L.P.; Lien, B.A.; Brun, O.S.; Schaak, D.D.; McDonough, K.A.; Chang, L.C. A Mycobacterium marinum zone of inhibition assay as a method for screening potential antimycobacterial compounds from marine extracts. Planta Med, 2007, 73, 559-563.
24. Chaturvedi, V.; Dwivedi, N.; Tripathi, R.P.; Sinha, S. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis. J. Gen. Appl. Microbiol., 2007, 53, 333-337.
25. Chung, G.A.; Aktar, Z.; Jackson, S.; Duncan, K. High-throughput screen for detecting antimycobacterial agents. Antimicrob. Agents Ch., 1995, 39, 2235-2238.
26. Gupta, A.; Bhakta, S.; Kundu, S.; Gupta, M.; Srivastava, B.S.; Srivastava, R. Fast-growing, non-infectious and intracellularly surviving drug-resistant Mycobacterium aurum: a model for highthroughput antituberculosis drug screening. J. Antimicrob. Chemoth., 2009, 64, 774-781.
27. Copp, B.R. Antimycobacterial natural products. Nat. Prod. Rep., 2003, 20, 535-557.
28. Copp, B.R.; Pearce, A.N. Natural product growth inhibitors of Mycobacterium tuberculosis. Nat. Prod. Rep., 2007, 24, 278-297.
29. Gutierrez-Lugo, M.T.; Bewley, C.A. Natural products, small molecules, and genetics in tuberculosis drug development. J. Med. Chem., 2008, 51, 2606-2612.
30. Palomino, J.C.; Ramos, D.F.; da Silva, P.A. New anti-tuberculosis drugs: Strategies, sources and new molecules. Curr. Med. Chem., 2009, 16, 1898-1904.
31. Fischbach, M.A.; Walsh, C.T. Antibiotics for emerging pathogens. Science, 2009, 325, 1089-1093.
32. de Souza, M.V.N. Promising candidates in clinical trials against multidrug-resistant tuberculosis (MDR-TB) based on natural products. Fitoterapia, 2009, 80, 453-460.
33. Stavri, M.; Mathew, K.T.; Gibbons, S. Antimicrobial constituents of Scrophularia deserti. Phytochemistry, 2006, 67, 1530-1533.
34. O'Donnell, G.; Gibbons, S. Antibacterial activity of two canthin-6- one alkaloids from Allium neapolitanum. Phytother. Res., 2007, 21, 653-657.
35. Kanokmedhakul, S.; Kanokmedhakul, K.; Lekphrom, R. Bioactive constituents of the roots of Polyalthia cerasoides. J. Nat. Prod., 2007, 70, 1536-1538.
36. Tasdemir, D.; Topaloglu, B.; Perozzo, R.; Brun, R.; O'Neill, R.; Carballeira, N.M.; Zhang, X.J.; Tonge, P.J.; Linden, A.; Ruedi, P. Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli. Bioorg. Med. Chem., 2007, 15, 6834-6845.
37. Kanokmedhakul, S.; Kanokmedhakul, K.; Kantikeaw, I.; Phonkerd, N. 2-substituted furans from the roots of Polyalthia evecta. J. Nat. Prod., 2006, 69, 68-72.
38. Ma, C.Y.; Case, R.J.; Wang, Y.H.; Zhang, H.J.; Tan, G.T.; Van Hung, N.; Cuong, N.M.; Franzblau, S.G.; Soejarto, D.D.; Fong, H.H.S.; Pauli, G.F. Anti-tuberculosis constituents from the stem bark of Micromelum hirsutum. Planta Med., 2005, 71, 261-267.
39. Yuan, H.; He, R.; Wan, B.J.; Wang, Y.H.; Pauli, G.F.; Franzblau, S.G.; Kozikowski, A.P. Modification of the side chain of micromolide, an anti-tuberculosis natural product. Bioorg. Med. Chem. Lett., 2008, 18, 5311-5315.
40. Adams, M.; Wube, A.A.; Bucar, F.; Bauer, R.; Kunert, O.; Haslinger, E. Quinolone alkaloids from Evodia rutaecarpa: a potent new group of antimycobacterial compounds. Int. J. Antimicrob. Agents, 2005, 26, 262-264.
41. Leon-Rivera, I.; Miron-Lopez, G.; Molina-Salinas, G.M.; Herrera-Ruiz, M.; Estrada-Soto, S.; Gutierrez, M.D.; Alonso-Cortes, D.; Navarrete-Vazquez, G.; Rios, M.Y.; Said-Fernandez, S. Tyrianthinic acids from Ipomoea tyrianthina and their antimycobacterial activity, cytotoxicity, and effects on the central nervous system. J. Nat. Prod., 2008, 71, 1686-1691.
42. Bandaranayake, W.M.; Banfield, J.E.; Black, D.S.C. Postulated electrocyclic reactions leading to endiandric acid and related natural-products. J. Chem. Soc.-Chem. Comm., 1980, 902-903.
43. Gravel, E.; Poupon, E. Biogenesis and biomimetic chemistry: Can complex natural products be assembled spontaneously? Eur. J. Org. Chem., 2008, 27-42.
44. Nicolaou, K.C.; Petasis, N.A.; Uenishi, J.; Zipkin, R.E. The endiandric acid cascade - Electrocyclizations in organic-synthesis.2. Stepwise, stereocontrolled total synthesis of endiandric acids c - acid g. J. Am. Chem. Soc., 1982, 104, 5557-5558.
45. Nicolaou, K.C.; Petasis, N.A.; Zipkin, R.E. The endiandric acid cascade - Electrocyclizations in organic-synthesis.4. Biomimetic approach to endiandric acids A - acid G - Total synthesis and thermal studies. J. Am. Chem. Soc., 1982, 104, 5560-5562.
46. Nicolaou, K.C.; Petasis, N.A.; Zipkin, R.E.; Uenishi, J. The endiandric acid cascade - Electrocyclizations in organic-synthesis.1. Stepwise, stereocontrolled total synthesis of endiandric acid A and acid B. J. Am. Chem. Soc., 1982, 104, 5555-5557.
47. Nicolaou, K.C.; Zipkin, R.E.; Petasis, N.A. The endiandric acid cascade - Electrocyclizations in organic-synthesis. 3. Biomimetic approach to endiandric acids A- acid-G - Synthesis of precursors. J. Am. Chem. Soc., 1982, 104, 5558-5560.
48. Kong, F.M.; Singh, M.P.; Carter, G.T. Pseudopyronines A and B, alpha-pyrones produced by a marine Pseudomonas sp F92S91, and evidence for the conversion of 4-hydroxy-alpha-pyrone to 3- furanone. J. Nat. Prod., 2005, 68, 920-923.
49. Singh, M.P.; Kong, F.M.; Janso, J.E.; Arias, D.A.; Suarez, P.A.; Bernan, V.S.; Petersen, P.J.; Weiss, W.J.; Carter, G.; Greenstein, M. Novel alpha-pyrones produced by a marine Pseudomonas sp F92S91: Taxonomy and biological activities. J. Antibiot., 2003, 56, 1033-1044.
50. Chu, M.; Mierzwa, R.; Xu, L.; He, L.; Terracciano, J.; Patel, M.; Zhao, W.; Black, T.A.; Chan, T.M. Structure of Sch 419560, a novel alpha-pyrone antibiotic produced by Pseudomonas fluorescens. J. Antibiot., 2002, 55, 215-218.
51. Giddens, A.C.; Nielsen, L.; Boshoff, H.I.; Tasdemir, D.; Perozzo, R.; Kaiser, M.; Wang, F.; Sacchettini, J.C.; Copp, B.R. Natural product inhibitors of fatty acid biosynthesis: Synthesis of the marine microbial metabolites pseudopyronines A and B and evaluation of their anti-infective activities. Tetrahedron, 2008, 64, 1242-1249.
52. Miller, C.H.; Nisa, S.; Dempsey, S.; Jack, C.; O'Toole, R. Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria. Antimicrob. Agents Ch., 2009, 53, 5279-5283.
53. Tuntiwachwuttikul, P.; Phansa, P.; Pootaeng-On, Y.; Taylor, W.C. Chemical constituents of the roots of Piper sarmentosum. Chem. Pharm. Bull., 2006, 54, 149-151.
54. Adams, M.; Ettl, S.; Kunert, O.; Wube, A.A.; Haslinger, E.; Bucar, F.; Bauer, R. Antimycobacterial activity of geranylated furocoumarins from Tetradium daniellii. Planta Med., 2006, 72, 1132-1135.
55. Steinmetz, H.; Irschik, H.; Kunze, B.; Reichenbach, H.; Hofle, G.; Jansen, R. Thuggacins, macrolide antibiotics active against Mycobacterium tuberculosis: Isolation from myxobacteria, structure elucidation, conformation analysis and biosynthesis. Chem.-Eur. J., 2007, 13, 5822-5832.
56. Irschik, H.; Reichenbach, H.; Höfle, G.; Jansen, R. The thuggacins, novel antibacterial macrolides from Sorangium cellulosum acting against selected gram-positive bacteria. J. Antibiot., 2007, 60, 733-738.
57. Chen, J.-J.; Chou, E.-T.; Peng, C.-F.; Chen, I.-S.; Yang, S.-Z.; Huang, H.-Y. Novel epoxyfuranoid lignans and antitubercular constituents from the leaves of Beilschmiedia tsangii. Planta Med., 2007, 73, 567-571.
58. Rangkaew, N.; Suttisri, R.; Moriyasu, M.; Kawanishi, K. A new acyclic diterpene acid and bioactive compounds from Knema glauca. Arch. Pharm. Res., 2009, 32, 685-692.
59. Weber, D.; Sterner, O.; Anke, T. Mollisianitrile, a new antibiotic from Mollisia sp. A59-96. Z. Naturforsch., 2007, 62c, 567-570.
60. Gu, J.Q.; Graf, T.N.; Lee, D.H.; Chai, H.B.; Mi, Q.W.; Kardono, L.B.S.; Setyowati, F.M.; Ismail, R.; Riswan, S.; Farnsworth, N.R.; Cordell, G.A.; Pezzuto, J.M.; Swanson, S.M.; Kroll, D.J.; Falkinham, J.O.; Wall, M.E.; Wani, M.C.; Kinghorn, A.D.; Oberlies, N.H. Cytotoxic and antimicrobial constituents of the bark of Diospyros maritima collected in two geographical locations in Indonesia. J. Nat. Prod., 2004, 67, 1156-1161.
61. Bapela, N.B.; Lall, N.; Fourie, P.B.; Franzblau, S.G.; Van Rensburg, C.E.J. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis. Phytomedicine, 2006, 13, 630-635.
62. Wu, C.-C.; Peng, C.-F.; Tsai, I.-L.; Abd El-Razek, M.H.; Huang, H.- S.; Chen, I.-S. Secondary metabolites from the roots of Engelhardia roxburghiana and their antitubercular activities. Phytochemistry, 2007, 68, 1338-1343.
63. Lin, W.Y.; Peng, C.F.; Tsai, I.L.; Chen, J.J.; Cheng, M.J.; Chen, I.S. Antitubercular constituents from the roots of Engelhardia roxburghiana. Planta Med., 2005, 71, 171-175.
64. Seibert, S.F.; Eguereva, E.; Krick, A.; Kehraus, S.; Voloshina, E.; Raabe, G.; Fleischhauer, J.; Leistner, E.; Wiese, M.; Prinz, H.; Alexandrov, K.; Janning, P.; Waldmann, H.; Konig, G.M. Polyketides from the marine-derived fungus Ascochyta salicorniae and their potential to inhibit protein phosphatases. Org. Biomol. Chem., 2006, 4, 2233-2240.
65. Stepanchikova, A.V.; Lagunin, A.A.; Filimonov, D.A.; Poroikov, V.V. Prediction of biological activity spectra for substances: Evaluation on the diverse sets of drug-like structures. Curr. Med. Chem., 2003, 10, 225.
66. Arai, K.; Rawlings, B.J.; Yoshizawa, Y.; Vederas, J.C. Biosyntheses of antibiotic A26771B by Penicillium turbatum and dehydrocurvularin by Alternaria cinerariae - comparison of stereochemistry of polyketide and fatty-acid enoyl thiol ester reductases. J. Am. Chem. Soc., 1989, 111, 3391-3399.
67. Hyeon, S.B.; Ozaki, A.; Suzuki, A.; Tamura, S. Isolation of α,β- dehydrocurvularin and β-hydroxycurvularin from Alternaria tomato as sporulation-suppressing factors. Agr. Biol. Chem., 1976, 40, 1663-1664.
68. Bicalho, B.; Goncalves, A.C.; Zibordi, A.P.M.; Manfio, G.P.; Marsaioli, A.J. Antimicrobial compounds of fungi vectored by Clusia spp. (Clusiaceae) pollinating bees. Z. Naturforsch., 2003, 58c, 746-751.
69. De Souza, A.O.; Galetti, F.C.S.; Silva, C.L.; Bicalho, B.; Parma, M.M.; Fonseca, S.F.; Marsaioli, A.J.; Trindade, A.C.L.B.; Gil, R.P.F.; Bezerra, F.S.; Andrade-Neto, M.; De Oliveira, M.C.F. Antimycobacterial and cytotoxicity activity of synthetic and natural compounds. Química Nova, 2007, 30, 1563-1566.
70. Sharma, S.K.; Parasuraman, P.; Kumar, G.; Surolia, N.; Surolia, A. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR). J. Med. Chem., 2007, 50, 765-775.
71. Tasdemir, D.; Lack, G.; Brun, R.; Ruedi, P.; Scapozza, L.; Perozzo, R. Inhibition of Plasmodium falciparum fatty acid biosynthesis: Evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. J. Med. Chem., 2006, 49, 3345-3353.
72. Zhang, Y.M.; Rock, C.O. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J. Biol. Chem., 2004, 279, 30994-31001.
73. Brown, A.K.; Papaemmanouil, A.; Bhowruth, V.; Bhatt, A.; Dover, L.G.; Besra, G.S. Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II. Microbiology, 2007, 153, 3314-3322.
74. Sassetti, C.M.; Boyd, D.H.; Rubin, E.J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol., 2003, 48, 77-84.
75. Chokchaisiri, R.; Suaisom, C.; Sriphota, S.; Chindaduang, A.; Chuprajob, T.; Suksamrarn, A. Bioactive flavonoids of the flowers of Butea monosperma. Chem. Pharm. Bull., 2009, 57, 428-432.
76. Chen, J.J.; Peng, C.F.; Huang, H.Y.; Chen, I.S. Benzopyrans, biphenyls and xanthones from the root of Garcinia linii and their activity against Mycobacterium tuberculosis. Planta Med., 2006, 72, 473-477.
77. Pecchio, M.; Solis, P.N.; Lopez-Perez, J.L.; Vasquez, Y.; Rodriguez, N.; Olmedo, D.; Correa, M.; San Feliciano, A.; Gupta, M.P. Cytotoxic and antimicrobial benzophenones from the leaves of Tovomita longifolia. J. Nat. Prod., 2006, 69, 410-413.
78. Hong, Q.; Minter, D.E.; Franzblau, S.G.; Reinecke, M.G. Antituberculosis compounds from two Bolivian medicinal plants, Senecio mathewsii and Usnea florida. Nat. Prod. Commun., 2008, 3, 1377-1384.
79. Ivanova, V.; Kolarova, M.; Aleksieva, K. Sanionins: Antiinflammatory and antibacterial agents with weak cytotoxicity from the Antartic moss Sanionia georgico-uncinata. Prep. Biochem. Biotechnol., 2007, 37, 343-352.
80. Han, L.; Huang, X.; Dahse, H.-M.; Moellmann, U.; Fu, H.; Grabley, S.; Sattler, I.; Lin, W. Unusual naphthoquinone derivatives from the twigs of Avicennia marina. J. Nat. Prod., 2007, 70, 923-927.
81. Camacho-Corona, M.D.; Favela-Hernandez, J.M.D.; Gonzalez-Santiago, O.; Garza-Gonzalez, E.; Molina-Salinas, G.M.; Said-Fernandez, S.; Delgado, G.; Luna-Herrerae, J. Evaluation of some plant-derived secondary metabolites against sensitive and multidrug-resistant Mycobacterium tuberculosis. J. Mex. Chem. Soc., 2009, 53, 71-75.
82. Camacho, M.D.; Kirby, G.C.; Warhurst, D.C.; Croft, S.L.; Phillipson, J.D. Oxoaporphine alkaloids and quinones from Stephania dinklagei and evaluation of their antiprotozoal activities. Planta Med., 2000, 66, 478-480.
83. Solis, P.N.; Langat, C.; Gupta, M.P.; Kirby, G.C.; Warhurst, D.C.; Phillipson, J.D. Bioactive compounds from Psychotria camponutans. Planta Med., 1995, 61, 62-65.
84. Tuntiwachwuttikul, P.; Phansa, P.; Pootaeng-On, Y.; Taylor, W.C. Chromones from the branches of Harrisonda perforata. Chem. Pharm. Bull., 2006, 54, 44-47.
85. Lekphrom, R.; Kanokmedhakul, S.; Kanokmedhakul, K. Bioactive styryllactones and alkaloid from flowers of Goniothalamus laoticus. J. Ethnopharmacol., 2009, 125, 47-50.
86. Koysomboon, S.; van Altena, I.; Kato, S.; Chantrapromma, K. Antimycobacterial flavonoids from Derris indica. Phytochemistry, 2006, 67, 1034-1040.
87. Gupta, V.K.; Fatima, A.; Faridi, U.; Negi, A.S.; Shanker, K.; Kumar, J.K.; Rahuja, N.; Luqman, S.; Sisodia, B.S.; Saikia, D.; Darokar, M.P.; Khanuja, S.P.S. Antimicrobial potential of Glycyrrhiza glabra roots. J. Ethnopharmacol., 2008, 116, 377-380.
88. Sutthivaiyakit, S.; Thongnak, O.; Lhinhatrakool, T.; Yodchun, O.; Srimark, R.; Dowtaisong, P.; Chuankamnerdkarn, M. Cytotoxic and antimycobacterial prenylated flavonoids from the roots of Eriosema chinense. J. Nat. Prod., 2009, 72, 1092-1096.
89. Rukachaisirikul, T.; Saekee, A.; Tharibun, C.; Watkuolham, S.; Suksamrarn, A. Biological activities of the chemical constituents of Erythrina stricta and Erythrina subumbrans. Arch. Pharm. Res., 2007, 30, 1398-1403.
90. Boonphong, S.; Baramee, A.; Kittakoop, P.; Puangsombat, P. Antitubercular and antiplasmodial prenylated flavones from the roots of Artocarpus altilis. Chang Mai J. Sci., 2007, 34, 339-344.
91. Namdaung, U.; Aroonrerk, N.; Suksamrarn, S.; Danwisetkanjana, K.; Saenboonrueng, J.; Arjchomphu, W.; Suksamrarn, A. Bioactive constituents of the root bark of Artocarpus rigidus subsp. rigidus. Chem. Pharm. Bull., 2006, 54, 1433-1436.
92. Khumkomkhet, P.; Kanokmedhakul, S.; Kanokmedhakul, K.; Hahnvajanawong, C.; Soytong, K. Antimalarial and cytotoxic depsidones from the fungus Chaetomium brasiliense. J. Nat. Prod., 2009, 72, 1487-1491.
93. Kokubo, S.; Suenaga, K.; Shinohara, C.; Tsuji, T.; Uemura, D. Structures of amamistatins A and B, novel growth inhibitors of human tumor cell lines from Nocardia asteroides. Tetrahedron, 2000, 56, 6435-6440.
94. Suenaga, K.; Kokubo, S.; Shinohara, C.; Tsuji, T.; Uemura, D. Structures of amamistatins A and B, novel growth inhibitors of human tumor cell lines from an actinomycete. Tet. Lett., 1999, 40, 1945-1948.
95. Fennell, K.A.; Mollmann, U.; Miller, M.J. Syntheses and biological activity of amamistatin B and analogs. J. Org. Chem., 2008, 73, 1018-1024.
96. Schwartz, B.D.; De Voss, J.J. Structure and absolute configuration of mycobactin J. Tet. Lett., 2001, 42, 3653-3655.
97. Koyama, N.; Kojima, S.; Fukuda, T.; Nagamitsu, T.; Yasuhara, T.; Omura, S.; Tomoda, H. Structure and total synthesis of fungal calpinactam, a new antimycobacterial agent. Org. Lett., 2009, 432-435.
98. Xie, Y.; Chen, R.; Si, S.; Sun, C.; Xy, H. A new nucleosidylpeptide antibiotic, sansanmycin. J. Antibiot., 2007, 60, 158-161.
99. Huang, X.; Roemer, E.; Sattler, I.; Moellmann, U.; Christner, A.; Grabley, S. Lydiamycins A-D: Cyclodepsipetides with antimycobacterial properties. Ang. Chem. Int. Ed., 2006, 45, 3067-3072.
100. Isaka, M.; Berkaew, P.; Intereya, K.; Komwijit, S.; Sathitkunanon, T. Antiplasmodial and antiviral cyclohexadepsipeptides from the endophytic fungus Pullularia sp. BCC 8613. Tetrahedron, 2007, 63, 6855-6860.
101. Muller, D.; Krick, A.; Kehraus, S.; Mehner, C.; Hart, M.; Kupper, F.C.; Saxena, K.; Prinz, H.; Schwalbe, H.; Janning, P.; Waldmann, H.; Konig, G.M. Brunsvicamides A-C: Sponge-related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity. J. Med. Chem., 2006, 49, 4871-4878.
102. Shilabin, A.G.; Kasanah, N.; Wedge, D.E.; Hamann, M.T. Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: Semisynthetic modifications and antifungal lead-exploration studies. J. Med. Chem., 2007, 50, 4340-4350.
103. Mukai, A.; Fukai, T.; Hoshino, Y.; Yazawa, K.; Harada, K.; Mikami, Y. Nocardithiocin, a novel thiopeptide antibiotic, produced by pathogenic Nocardia pseudobrasiliensis IFM 0757. J. Antibiot., 2009, 62, 613-619.
104. Jayasinghe, L.; Abbas, H.K.; Jacob, M.R.; Herath, W.H.M.W.; Nanayakkara, N.P.D. N-Methyl-4-hydroxy-2-pyridinone analogues from Fusarium oxysporum. J. Nat. Prod., 2006, 69, 439-442.
105. Iwatsuki, M.; Tomoda, H.; Uchida, R.; Gouda, H.; Hirono, S.; Omura, S. Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-B0171, have a lasso structure. J. Am. Chem. Soc., 2006, 128, 7486-7491.
106. Iwatsuki, M.; Uchida, R.; Takakusagi, Y.; Matsumoto, A.; Jiang, C.-L.; Takahashi, Y.; Arai, M.; Kobayashi, S.; Matsumoto, M.; Inokoshi, J.; Tomoda, H.; Omura, S. Lariatins, novel antimycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171. J. Antibiot., 2007, 60, 357-363.
107. Kimura, K.-I.; Yamazaki, M.; Sasaki, N.; Yamashita, T.; Negishi, S.; Nakamura, T.; Koshino, H. Novel propeptin analog, propeptin-2, missing two amino acid residues from the propeptin C-terminus loses antibiotic potency. J. Antibiot., 2007, 60, 519-523.
108. Mukai, A.; Fukai, T.; Matsumoto, Y.; Ishikawa, J.; Hoshino, Y.; Yazawa, K.; Harada, K.-I.; Mikami, Y. Transvalencin Z, a new antimicrobial compound with salicyclic acid residue from Nocardia transvalensis IFM 10065. J. Antibiot., 2006, 59, 366-369.
109. De Oliveira, M.F.; de Oliveira, J.; Galetti, F.C.S.; De Souza, A.O.; Silva, C.L.; Hajdu, E.; Peixinho, S.; Berlinck, R.G.S. Antimycobacterial brominated metabolites from two species of marine sponges. Planta Med., 2006, 72, 437-441.
110. Arai, M.; Sobou, M.; Vilcheze, C.; Baughn, A.; Hashizume, H.; Pruksakorn, P.; Ishida, S.; Matsumoto, M.; Jacobs, W.R.; Kobayashi, M. Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent. Bioorg. Med. Chem., 2008, 16, 6732-6736.
111. Jaspars, M.; Pasupathy, V.; Crews, P. A tetracyclic diamine alkaloid, halicyclamine-A, from the marine sponge Haliclona sp. J. Org. Chem., 1994, 59, 3253-3255.
112. Arai, M.; Ishida, S.; Settawan, A.; Kobayashi, M. Haliclonacyclamines, tetracyclic alkylpiperidine alkaloids, as antidormant mycobacterial substances from a marine sponge of Haliclona sp. Chem. Pharm. Bull., 2009, 57, 1136-1138.
113. de Oliveira, J.H.H.L.; Seleghim, M.H.R.; Timm, C.; Grube, A.; Kock, M.; Nascimento, G.G.F.; Martins, A.C.T.; Silva, E.G.O.; de Souza, A.O.; Minarini, P.R.R.; Galetti, F.C.S.; Silva, C.L.; Hajdu, E.; Berlinck, R.G.S. Antimicrobial and antimycobacterial activity of cyclostellettamine alkaloids from sponge Pachychalina sp. Mar. Drugs, 2006, 4, 1-8.
114. Guo, S.; Tipparaju, S.K.; Pegan, S.D.; Wan, B.; Mo, S.; Orjala, J.; Mesecar, A.D.; Franzblau, S.G.; Kozikowski, A.P. Natural product leads for drug discovery: isolation, synthesis and biological evaluation of 6-cyano-5-methoxyindolo [2,3-a]carbazole based ligands as antibacterial agents. Bioorg. Med. Chem., 2009, 17, 7126-7130.
115. Knubel, G.; Larsen, L.K.; Moore, R.E.; Levine, I.A.; Patterson, G.M.L. Cytotoxic, antiviral indolocarbazoles from a blue-greenalga belonging to the Nostocaceae. J. Antibiot., 1990, 43, 1236-1239.
116. Mo, S.Y.; Krunic, A.; Chlipala, G.; Orjala, J. Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua. J. Nat. Prod., 2009, 72, 894-899.
117. Kemami Wangun, H.V.; Hertweck, C. Epicoccarines A, B and epipyridone: tetramic acids and pyridone alkaloids from an Epicoccum sp. associated with the tree fungus Pholiota squarrosa. Org. Biomol. Chem., 200, 5, 1702-1705.
118. Proszenyak, A.; Charnock, C.; Hedner, E.; Larsson, R.; Bohlin, L. Synthesis, antimicrobial and antineoplastic activities for agelasine and agelasimine analogs with a _-cyclocitral derived substituent. Arch. Pharm. Chem. Life Sci., 2007, 340, 625-634.
119. Vik, A.; Hedner, E.; Charnock, C.; Samuelsen, O.; Larsson, R.; Gundersen, L.L.; Bohlin, L. (+)-agelasine D: Improved synthesis and evaluation of antibacterial and cytotoxic activities. J. Nat. Prod., 2006, 69, 381-386.
120. Seephonkai, P.; Kongsaeree, P.; Prabpai, S.; Isaka, M.; Thebtaranonth, Y. Transformation of an irregularly bridged epidithiodiketopiperazine to trichodermamide A. Org. Lett., 2006, 8, 3073-3075.
121. Chinworrungsee, M.; Kittakoop, P.; Saenboonrueng, J.; Kongsaeree, P.; Thebtaranonth, Y. Bioactive compounds from the seed fungus Menisporopsis theobromae BCC 3975. J. Nat. Prod., 2006, 69, 1404-1410.
122. Hua, H.-M.; Peng, J.; Dunbar, D.C.; Schinazi, R.F.; de Castro Andrews, A.G.; Cuevas, C.; Garcia-Fernandez, L.F.; Kelly, M.; Hamann, M.T. Batzelladine alkaloids from the Caribbean sponge Monanchora unguifera and the significant activities against HIV-1 and AIDS opportunistic infectious pathogens. Tetrahedron, 2007, 63, 11179-11188.
123. Sakai, R.; Higa, T.; Jefford, C.W.; Bernardinelli, G. Manzamine A, a novel antitumor alkaloid from a sponge. J. Am. Chem. Soc., 1986, 108, 6404-6405.
124. Rao, K.V.; Donia, M.S.; Peng, J.N.; Garcia-Palomero, E.; Alonso, D.; Martinez, A.; Medina, M.; Franzblau, S.G.; Tekwani, B.L.; Khan, S.I.; Wahyuono, S.; Willett, K.L.; Hamann, M.T. Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases. J. Nat. Prod., 2006, 69, 1034-1040.
125. Wahba, A.E.; Peng, J.; Kudrimoti, S.; Tekwani, B.L.; Hamann, M.T. Structure-activity relationship studies of manzamine A: Amidation of positions 6 and 8 of the _-carboline moiety. Bioorg. Med. Chem., 2009, 17, 7775-7782.
126. Sayed, K.A.E.; Khalil, A.A.; Yousaf, M.; Labadie, G.; Kumar, G.M.; Franzblau, S.G.; Mayer, A.M.S.; Avery, M.A.; Hamann, M.T. Semisynthetic studies on the manzamine alkaloids. J. Nat. Prod., 2008, 71, 300-308.
127. Winkler, J.D.; Londregan, A.T.; Hamann, M.T. Synthetic modification of manzamine A via Grubbs metathesis. Novel structures with enhanced antibacterial and antiprotozoal properties. Org. Lett., 2007, 9, 4467-4469.
128. Isaka, M.; Prathumpai, W.; Wongsa, P.; Tanticharoen, M. Hirsutellone F, a dimer of antitubercular alkaloids from the seed fungus Trichoderma species BCC 7579. Org. Lett., 2006, 8, 2815-2817.
129. Copp, B.R.; Pierce, A.N. Natural product growth inhibitors of Mycobacterium tuberculosis. Nat. Prod. Rep., 2007, 24, 278-297.
130. Melo, M.D.; Santos, C.A.D.; Chiappeta, A.D.; Demello, J.F.; Mukherjee, R. Chemistry and pharmacology of a tertiary alkaloid from Strychnos trinervis root bark. J. Ethnopharmacol., 1987, 19, 319-325.
131. Aponte, J.C.; Vaisberg, A.J.; Rojas, R.; Caviedes, L.; Lewis, W.H.; Lamas, G.; Sarasara, C.; Gilman, R.H.; Hammond, G.B. Isolation of cytotoxic metabolites from targeted Peruvian amazonian medicinal plants. J. Nat. Prod., 2008, 71, 102-105.
132. O'Donnell, G.; Poeschl, R.; Zimhony, O.; Gunaratnam, M.; Moreira, J.B.C.; Neidle, S.; Evangelopoulos, D.; Bhakta, S.; Malkinson, J.P.; Boshoff, H.I.; Lenaerts, A.; Gibbons, S. Bioactive pyridine-N-oxide disulfides from Allium stipitatum. J. Nat. Prod., 2009, 72, 360-365.
133. Dettrakul, S.; Surerum, S.; Rajviroongit, S.; Kittakoop, P. Biomimetic transformation and biological activities of globiferin, a terpenoid benzoquinone from Cordia globifera. J. Nat. Prod., 2009, 72, 861-865.
134. Gordien, A.Y.; Gray, A.I.; Franzblau, S.G.; Seidel, V. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae). J. Ethnopharmacol., 2009, 126, 500-505.
135. Chapman, A.C. Essential oil of hops. J. Chem. Soc. Trans., 1895, 67, 54-63.
136. Yang, P.S.; Cheng, M.J.; Peng, C.F.; Chen, J.J.; Chen, L.S. Endiandric acid analogues from the roots of Beilschmiedia erythrophloia. J. Nat. Prod., 2009, 72, 53-58.
137. Wang, G.H.; Ahmed, A.F.; Sheu, J.H.; Duh, C.Y.; Shen, Y.C.; Wang, L.T. Suberosols A-D, four new sesquiterpenes with betacaryophyllene skeletons from a Taiwanese gorgonian coral Subergorgia suberosa. J. Nat. Prod., 2002, 65, 887-891.
138. Vongvanich, N.; Kittakoop, P.; Charoenchai, P.; Intamas, S.; Sriklung, K.; Thebtaranonth, Y. Antiplasmodial, antimycobacterial, and cytotoxic principles from Camchaya calcarea. Planta Med., 2006, 72, 1427-1430.
139. Chou, T.H.; Chen, I.S.; Sung, P.J.; Peng, C.F.; Shieh, P.C.; Chen, J.J. A new dihydroagarofuranoid sesquiterpene from Microtropis fokienensis with antituberculosis activity. Chem. Biodiv., 2007, 4, 1594-1600.
140. Chen, J.J.; Chou, T.H.; Peng, C.F.; Chen, I.S.; Yang, S.Z. Antitubercular dihydroagarofuranoid sesquiterpenes from the roots of Microtropis fokienensis. J. Nat. Prod., 2007, 70, 202-205.
141. Chen, J.J.; Yang, C.S.; Peng, C.F.; Chen, I.S.; Miaw, C.L. Dihydroagarofuranoid sesquiterpenes, a lignan derivative, a benzenoid, and antitubercular constituents from the stem of Microtropis japonica. J. Nat. Prod., 2008, 71, 1016-1021.
142. Chou, T.H.; Chen, I.S.; Peng, C.F.; Sung, P.J.; Chen, J.J. A new dihydroagarofuranoid sesquiterpene and antituberculosis constituents from the root of Microtropis japonica. Chem. Biodiv., 2008, 5, 1412-1418.
143. Gul, W.; Hammond, N.L.; Yousaf, M.; Peng, J.; Holley, A.; Hamann, M.T. Chemical transformation and biological studies of marine sesquiterpene (S)-(+)-curcuphenol and its analogs. BBAGen. Sub., 2007, 1770, 1513-1519.
144. Chen, J.J.; Wu, H.M.; Peng, C.F.; Chen, I.S.; Chu, S.D. seco- Abietane diterpenoids, a phenylethanoid derivative, and antitubercular constituents from Callicarpa pilosissima. J. Nat. Prod., 2009, 72, 223-228.
145. Shi, Y.P.; Wei, X.; Rodriguez, II; Rodriguez, A.D.; Mayer, A.M.S. New terpenoid constituents of the southwestern caribbean sea whip Pseudopterogorgia elisabethae (Bayer), including a unique pentanorditerpene. Eur. J. Org. Chem., 2009, 493-502.
146. Rodriguez, A.D.; Gonzalez, E.; Huang, S.D. Unusual terpenes with novel carbon skeletons from the West Indian sea whip Pseudopterogorgia elisabethae (Octocorallia). J. Org. Chem., 1998, 63, 7083-7091.
147. Hussein, A.A.; Meyer, J.J.M.; Jimeno, M.L.; Rodriguez, B. Bioactive diterpenes from Orthosiphon labiatus and Salvia africana-lutea. J. Nat. Prod., 2007, 70, 293-295.
148. Encarnacion-Dimayuga, R.; Agundez-Espinoza, J.; Garcia, A.; Delgado, G.; Molina-Salinas, G.M.; Said-Fernandez, S. Two new cassane-type diterpenes from Calliandra californica with antituberculosis and cytotoxic activities. Planta Med., 2006, 72, 757-761.
149. Singh, S.B.; Jayasuriya, H.; Ondeyka, J.G.; Herath, K.B.; Zhang, C.W.; Zink, D.L.; Tsou, N.N.; Ball, R.G.; Basilio, A.; Genilloud, O.; Diez, M.T.; Vicente, F.; Pelaez, F.; Young, K.; Wang, J. Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy. J. Am. Chem. Soc., 2006, 128, 11916-11920.
150. Wang, J.; Kodali, S.; Lee, S.H.; Galgoci, A.; Painter, R.; Dorso, K.; Racine, F.; Motyl, M.; Hernandez, L.; Tinney, E.; Colletti, S.L.; Herath, K.; Cummings, R.; Salazar, O.; Gonzalez, I.; Basilio, A.; Vicente, F.; Genilloud, O.; Pelaez, F.; Jayasuriya, H.; Young, K.; Cully, D.F.; Singh, S.B. Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties. Proc. Natl. Acad. Sci. USA, 2007, 104, 7612-7616.
151. Wang, J.; Soisson, S.M.; Young, K.; Shoop, W.; Kodali, S.; Galgoci, A.; Painter, R.; Parthasarathy, G.; Tang, Y.S.; Cummings, R.; Ha, S.; Dorso, K.; Motyl, M.; Jayasuriya, H.; Ondeyka, J.; Herath, K.; Zhang, C.W.; Hernandez, L.; Allocco, J.; Basilio, A.; Tormo, J.R.; Genilloud, O.; Vicente, F.; Pelaez, F.; Colwell, L.; Lee, S.H.; Michael, B.; Felcetto, T.; Gill, C.; Silver, L.L.; Hermes, J.D.; Bartizal, K.; Barrett, J.; Schmatz, D.; Becker, J.W.; Cully, D.; Singh, S.B. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature, 2006, 441, 358-361.
152. Brown, A.K.; Taylor, R.C.; Bhatt, A.; Futterer, K.; Besra, G.S. Platensimycin activity against mycobacterial beta-ketoacyl-ACP synthases. PLoS One, 2009, 4, e6306.
153. Mongkolvisut, W.; Sutthivaiyakit, S. Antimalarial and antituberculous poly-O-acylated jatrophane diterpenoids from Pedilanthus tithymaloides. J. Nat. Prod., 2007, 70, 1434-1438.
154. Noro, J.C.; Barrows, L.R.; Gideon, O.G.; Ireland, C.M.; Koch, M.; Matainaho, T.; Piskaut, P.; Pond, C.D.; Bugni, T.S. Tetrahdroxysqualene from Rhus taitensis shows antimycobacterial activity against Mycobacterium tuberculosis. J. Nat. Prod., 2008, 71, 1623-1624.
155. Antinori, F.; Bock, C. Activity of squalene on Mycobacterium tuberculosis in vitro and in vivo. Riv Ital Ig, 1956, 16, 183-187.
156. Jimenez, A.; Meckes, M.; Alvarez, V.; Torres, J.; Parra, R. Secondary metabolites from Chamaedora tepejilote (Palmae) are active against Mycobacterium tuberculosis. Phytother. Res., 2005, 19, 320-322.
157. Tan, M.A.; Takayama, H.; Aimi, N.; Kitajima, M.; Franzblau, S.G.; Nonato, M.G. Antitubercular triterpenes and phytosterols from Pandanus tectorius Soland. var. laevis. J. Nat. Med., 2008, 62, 232-235.
158. Pattamadilok, D.; Suttisri, R. Seco-terpenoids and other constituents from Elateriospermum tapos. J. Nat. Prod., 2008, 71, 292-294.
159. Suksamrarn, S.; Panseeta, P.; Kunchanawata, S.; Distaporn, T.; Ruktasing, S.; Suksamrarn, A. Ceanothane- and lupane-type triterpenes with antiplasmodial and antimycobacterial activities from Ziziphus cambodiana. Chem. Pharm. Bull., 2006, 54, 535-537.
160. Rojas, R.; Caviedes, L.; Aponte, J.C.; Vaisberg, A.J.; Lewis, W.H.; Lamas, G.; Sarasara, C.; Gilman, R.H.; Hammond, G.B. Aegicerin, the first oleanane triterpene with wide-ranging antimycobacterial activity, isolated from Clavija procera. J. Nat. Prod., 2006, 69, 845-846.
161. Wei, X.; Rodríguez, A.D.; Wang, Y.; Franzblau, S.G. Novel ring B abeo-sterols as growth inhibitors of Mycobacterium tuberculosis isolated from a Caribbean Sea sponge, Svenzea zeai. Tetrahedron Lett., 2007, 48, 8851-8854.
162. Cateni, F.; Doljak, B.; Zacchigna, M.; Anderluh, M.; Piltaver, A.; Scialino, G.; Banfi, E. New biologically active epidioxysterols from Stereum hirsutum. Bioorg. Med. Chem. Lett., 2007, 17, 6330-6334.
163. Moosophon, P.; Kanokmedhakul, S.; Kanokmedhakul, K.; Soytong, K. Prenylxanthones and a bicycle [3.3.1]nona-2,6-diene derivative from the fungus Emericella rugulosa. J. Nat. Prod., 2009, 72, 1442-1446.
164. Oishi, H.; Noto, T.; Sasaki, H.; Suzuki, K.; Hayashi, T.; Okazaki, H.; Ando, K.; Sawada, M. Thiolactomycin, a new antibiotic. 1. Taxonomy of the producing organism, fermentation and biological properties. J. Antibiot., 1982, 35, 391-395.
165. Bhatt, A.; Molle, V.; Besra, G.S.; Jacobs, W.R.; Kremer, L. The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. Mol. Microbiol., 2007, 64, 1442-1454.
166. Choi, K.H.; Kremer, L.; Besra, G.S.; Rock, C.O. Identification and substrate specificity of beta-ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. J. Biol. Chem., 2000, 275, 28201-28207.
167. Kremer, L.; Douglas, J.D.; Baulard, A.R.; Morehouse, C.; Guy, M.R.; Alland, D.; Dover, L.G.; Lakey, J.H.; Jacobs, W.R.; Brennan, P.J.; Minnikin, D.E.; Besra, G.S. Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J. Biol. Chem., 2000, 275, 16857-16864.
168. Price, A.C.; Choi, K.H.; Heath, R.J.; Li, Z.M.; White, S.W.; Rock, C.O. Inhibition of beta-ketoacyl-acyl carrier protein syntheses by thiolactomycin and cerulenin - Structure and mechanism. J. Biol. Chem., 2001, 276, 6551-6559.
169. Luckner, S.R.; Machutta, C.A.; Tonge, P.J.; Kisker, C. Crystal structures of Mycobacterium tuberculosis KasA show mode of action within cell wall biosynthesis and its Inhibition by thiolactomycin. Structure, 2009, 17, 1004-1013.
170. Bhowruth, V.; Brown, A.K.; Senior, S.J.; Snaith, J.S.; Besra, G.S. Synthesis and biological evaluation of a C5-biphenyl thiolactomycin library. Bioorg. Med. Chem. Lett., 2007, 17, 5643-5646.
171. Douglas, J.D.; Senior, S.J.; Morehouse, C.; Phetsukiri, B.; Campbell, I.B.; Besra, G.S.; Minnikin, D.E. Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activity. Microbiology-Sgm, 2002, 148, 3101-3109.
172. Senior, S.J.; Illarionov, P.A.; Gurcha, S.S.; Campbell, I.B.; Schaeffer, M.L.; Minnikin, D.E.; Besra, G.S. Acetylene-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme. Bioorg. Med. Chem. Lett., 2004, 14, 373-376.
173. Senior, S.J.; Illarionova, P.A.; Gurcha, S.S.; Campbell, I.B.; Schaeffer, M.L.; Minnikin, D.E.; Besra, G.S. Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme. Bioorg. Med. Chem. Lett., 2003, 13, 3685-3688.
174. Al-Balas, Q.; Anthony, N.G.; Al-Jaidi, B.; Alnimr, A.; Abbott, G.; Brown, A.K.; Taylor, R.C.; Besra, G.S.; McHugh, T.D.; Gillespie, S.H.; Johnston, B.F.; Mackay, S.P.; Coxon, G.D. Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the beta-ketoacyl-ACP synthase mtFabH. PLoS One, 2009, 4, e5617.
175. Igarahi, M.; Nakagawa, N.; Doi, N.; Hattori, S.; Naganawa, H.; Hamada, M. Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp. J. Antibiot., 2003, 56, 580-583.
176. Igarashi, M.; Takahashi, Y.; Shitara, T.; Nakamura, H.; Naganawa, H.; Miyake, T.; Akamatsu, Y. Caprazamycins, novel liponucleoside antibiotics, from Streptomyces sp. J. Antibiot., 2005, 58, 327-337.
177. Dini, C. MraY inhibitors as novel antibacterial agents. Curr. Top. Med. Chem., 2005, 5, 1221-1236.
178. Hirano, S.; Ichikawa, S.; Matsuda, A. Total synthesis of caprazol, a core structure of the caprazamycin antituberculosis antibiotics. Ang. Chem. Int. Ed., 2005, 44, 1854-1856.
179. Hirano, S.; Ichikawa, S.; Matsuda, A. Development of a highly beta-selective ribosylation reaction without using neighboring group participation: Total synthesis of (+)-caprazol, a core structure of caprazamycins. J. Org. Chem., 2007, 72, 9936-9946.
180. Hirano, S.; Ichikawa, S.; Matsuda, A. Synthesis of caprazamycin analogues and their structure - activity relationship for antibacterial activity. J. Org. Chem., 2008, 73, 569-577.
181. Kaysser, L.; Lutsch, L.; Siebenberg, S.; Wemakor, E.; Kammerer, B.; Gust, B. Identification and manipulation of the caprazamycin gene cluster lead to new simplified liponucleoside antibiotics and give insights into the biosynthetic pathway. J. Biol. Chem., 2009, 284, 14987-14996.
182. Field, S.K.; Cowie, R.L. Lung disease due to the more common - Nontuberculous mycobacteria. Chest, 2006, 129, 1653-1672.